Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
Clinical trial NCT05753566 · RECRUITING
Trial details
- NCT number
- NCT05753566
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.